Trial of Lixisenatide in Early Parkinson’s DiseaseWassilios G. Meissner, Olivier Rascol, Pascal Derkinderen et al.|New England Journal of Medicine|2024Cited by 302
Foxa1 and Foxa2 Are Required for the Maintenance of Dopaminergic Properties in Ventral Midbrain Neurons at Late Embryonic StagesSimon Stott, Siew‐Lan Ang|Journal of Neuroscience|2013Cited by 86